Incidence and risk factors for intravenous immunoglobulin‐related hemolysis: A systematic review of clinical trial and real‐world populations
Author:
Affiliation:
1. CSL Behring King of Prussia Pennsylvania USA
2. CSL Behring AG Bern Switzerland
3. CSL Behring Innovation GmbH Marburg Germany
4. CSL Limited, Parkville Melbourne Australia
Funder
Fonds de dotation CSL Behring pour la recherche
Publisher
Wiley
Subject
Hematology,Immunology,Immunology and Allergy
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.17028
Reference51 articles.
1. Update on the use of immunoglobulin in human disease: A review of evidence
2. The role of isoagglutinins in intravenous immunoglobulin-related hemolysis
3. Anti-A and anti-B: what are they and where do they come from?
4. Hemolytic Transfusion Reactions
5. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A retrospective analysis of haemolytic reactions to intravenous immunoglobulin using data from the Transfusion‐Transmitted Injuries Surveillance System (Ontario);Vox Sanguinis;2023-08-17
2. Biochemical Characterization of a New 10% IVIG Preparation [IgG Next Generation (BT595)/Yimmugo®] Obtained from a Manufacturing Process Preserving IgA/IgM Potential of Human Plasma;Drugs in R&D;2023-07-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3